STOCKHOLM, March 8, 2019 /PRNewswire/ — 91 out of a total of 106 patienter with type 1 diabetes are included in the European phase IIb trial DIAGNODE-2, where the diabetes vaccine Diamyd® is given directly into the lymph node with the aim to preserve the patients’ endogenous insulin production. As…